Basivertebral Nerve Ablation for Vertebrogenic Low Back Pain

Guideline Support and Recommendations

The American Society of Pain and Neuroscience (ASPN) issues a strong recommendation with Level A grade evidence for BVN ablation in appropriately selected patients, indicating high certainty that the net benefit is substantial 1
The 2025 BMJ clinical practice guideline provides a strong recommendation FOR basivertebral nerve ablation for chronic back pain, representing a significant departure from recommendations against most other interventional spine procedures 1
The 2025 BMJ guideline issued strong recommendations AGAINST most common interventional procedures for chronic spine pain, including joint radiofrequency ablation, epidural steroid injections, facet joint injections, and intramuscular trigger point injections 2

Patients must meet specific clinical criteria for BVN ablation to be medically necessary, including ≥6 months of failed conservative management, which may include physical therapy 3, NSAIDs and/or other analgesics 3, activity modification 3, and other appropriate non-surgical interventions 2
The diagnosis of vertebrogenic pain is established through clinical presentation, MRI findings, and exclusion of other pain generators, without requiring prior diagnostic nerve blocks 4, 3

BVN ablation stands alone as having a strong FOR recommendation in the 2025 BMJ guideline, making it uniquely supported among interventional spine procedures 1
The randomized controlled trial supporting BVN ablation demonstrated mean ODI improvement and VAS pain reduction, with benefits maintained at 2-year follow-up, although the specific data is not directly cited 1, 2

The risk of prolonged pain or stiffness after basivertebral nerve ablation is 8.6%, the risk of temporary altered level of consciousness is 2.1%, the risk of dural puncture is 1.4%, and the risk of deep infection is 0.7% in patients undergoing the procedure, according to the BMJ guideline 5
Infection resulting in meningitis, spinal cord injury, and paraplegia are very rare but potential catastrophic harms associated with basivertebral nerve ablation, as reported in the BMJ guideline 5

The BMJ guideline suggests that if effective, nerve ablation procedures like basivertebral nerve ablation are typically repeated approximately every 6 months 5
The average cost for radiofrequency ablation in the US is approximately $6,000, and patients must travel to a clinic or hospital that administers the procedure, which may be a barrier unless government or private insurance covers the cost, as stated in the BMJ guideline 5